Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Attention centers on the FDAs pending decision on Capricors deramiocel therapy for Duchenne muscular dystrophy, with traders betting on approval and pointing to recent hiring and the FDAs approval of another rare-disease therapy as supportive signals. The community is also debating the risk of a rejection or narrower label, while many attribute the share move to short covering or speculate about a leakneither of which is confirmed.

AMD is drawing attention ahead of its quarterly report, with traders focused on whether AI and data-center demand can support strong forward guidance despite Intels warning about PC demand. Bullish traders see room for growth after the recent chip-stock selloff, while bears argue that even a solid report may be met with selling amid weak reactions to tech earnings and valuation concerns.

U.S. midterm elections dominate discussion, with traders linking DJTs rebound to election-related positioning and debating how a Democratic blue wave or Republican hold could affect the stock. Bullish posts point to election hopes and possible short covering, while bearish traders warn of further downside and describe the move as a temporary pump.

Attention is centered on Super Micros quarterly results and outlook, with traders weighing an upbeat preliminary revenue update against concerns about margins, cash flow, inventory, and management credibility. Bulls see strong results and guidance as a chance to reverse the selloff, while bears argue that weak margins or cautious guidance could outweigh a revenue beat.

Pfizers quarterly results beat expectations and the company raised its full-year outlook, but shares fell despite the upbeat report. Traders debate whether growth in newer, non-COVID products and cost cuts can offset declining COVID sales and looming patent expirations; bulls also point to the dividend and portfolio transition, while skeptics question the durability of the turnaround.

Madrigals strong Q3 Rezdiffra growth and first profitable quarter are drawing attention, but the shares sold off as traders debated whether profitability can last amid continued investment and a later clinical-outcomes readout. Some also flagged the whistleblower-retaliation lawsuit disclosed in the 10-Q as a possible overhang; its implications remain uncertain.

Traders are focused on Aristas upcoming quarterly earnings, with bullish options positioning and optimism about AI data-center networking demand. Sentiment is broadly hopeful, but some are wary of a large post-earnings move and the stocks history of fading after strong results.

IEPs quarterly update keeping its distribution unchanged has eased some fears of an immediate cut, while reported losses tied to refining hedges and CVR Energys refinery acquisition keep concerns about sustainability in focus. Traders are split between seeing the payout and refinery expansion as support and worrying that losses and dilution could pressure the partnership.

Midterm election uncertainty is dominating SPY discussion, with traders describing choppy, directionless trading as they position for results. The community is split between expecting a relief rally once uncertainty clears and fearing a selloff if one party sweeps Congress; AMD earnings and concerns about AI stocks are secondary topics.

Duolingos post-earnings selloff is drawing attention as traders focus on softer revenue guidance despite solid results and strong user growth. Bulls emphasize engagement, profitability and possible short-covering, while bears question monetization, valuation and whether AI could weaken the products appeal.